NCT02361216View on ClinicalTrials.gov

Efficacy and Safety of Ingenol Mebutate Gel for Actinic Keratosis Applied on Large Area on Face, Scalp or Chest

PHASE3CompletedINTERVENTIONAL
Enrollment

729

Participants

Timeline

Start Date

April 30, 2015

Primary Completion Date

March 31, 2016

Study Completion Date

March 31, 2017

Conditions
Actinic Keratosis
Interventions
DRUG

Ingenol Mebutate

OTHER

Vehicle

Vehicle gel

Trial Locations (1)

46032

Laser & Skin Surgery Center of Indiana, Carmel

Sponsors

Lead Sponsor

LEO Pharma
All Listed Sponsors
lead

LEO Pharma

INDUSTRY